Last reviewed · How we verify
High dose KT07
At a glance
| Generic name | High dose KT07 |
|---|---|
| Also known as | Lianhua Qingwen |
| Sponsor | Yiling Pharmaceutical Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase I Pharmacokinetics Study for KT07 Capsule (PHASE1)
- A Clinical Trial of KT07 Capsule in the U.S.A (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |